Entera Bio Ltd (ENTX)

Entera Bio Ltd (ENTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $435M; returns 1 day -3.3%, 1 week +9.0%, 1 year +36.4%.

Entera Bio Ltd. (ENTX) is a clinical-stage biopharmaceutical company focused on developing orally delivered macromolecule therapeutics using its proprietary N-Tab™ platform, which is designed to stabilize peptides in the gastrointestinal tract and enhance their absorption into the bloodstream.

Groups ENTX belongs to

• Clinical Stage Biotech
• Israel Companies
• Biotechnology
• Biopharmaceutical
• Life Sciences
• Healthcare
• Clinical Stage
• Unmet Medical Needs
• R&D
• Israel
• Drug Discovery
• Endocrinology

ENTX financial model: income statement, cash flow and balance sheet